🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Status
Terminated
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-06
Trial ID
NCT00704938
This study investigates the impact and adhesion of new adhesives to the ski...
Status
Completed
Location
Coloplast A/S
Start Date
2017-07-03
Trial ID
NCT03200444
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Completed
Location
Veterans Affairs Medical Center - Palo Alto
Start Date
2005-05-09
Trial ID
NCT00071981
RATIONALE: Giving chemotherapy and total marrow irradiation before a donor ...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2012-08
Trial ID
NCT00686556
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
2000-11
Trial ID
NCT00006363
Phase 1 - Safety and Proof of Concept...
Status
Terminated
Location
University of Pennsylvania
Start Date
2023-02-06
Trial ID
NCT05623488
Treatments Being Tested
The purpose of this study is to determine whether stem cells collected from...
Status
Completed
Location
UPMC Hillman Cancer Center
Start Date
2015-02-11
Trial ID
NCT02167958
The objective of this clinical trial is to evaluate, in clinically healthy ...
Status
Completed
Location
Health School-Polytechnic Institute of Coimbra
Start Date
2023-02-02
Trial ID
NCT07205237
Treatments Being Tested
Polycystic ovary syndrome (PCOS) is a common condition that can cause irreg...
Status
Completed
Location
Pakistan Institute of Health Sciences / Islamabad Medical and Dental College (IMDC)
Start Date
2025-05-21
Trial ID
NCT07380841
This is a multi-institutional Phase I/II study of an allogeneic KIR-HLA mis...
Status
Recruiting
Location
Mark Juckett, MD
Start Date
2026-05-08
Trial ID
NCT07591649
Treatments Being Tested